Skip to main content
Premium Trial:

Request an Annual Quote

BioGx Gets CE Marking for Six Meningitis, Antibiotic Resistance Tests

NEW YORK (GenomeWeb) – BioGx announced today that it has received CE marking for six tests for various meningitis infections and antibiotic-resistant organisms.

The tests are designed to run on Becton Dickinson's PCR-based BD Max platform. The meningitis tests cover viral meningitis based on DNA from HSV-1, HSV-2, and VZV; bacterial meningitis based on DNA from Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae; and bacterial meningitis ELGBS based on DNA from Escherichia coliListeria spp., and Group B Streptococcus.

The antibiotic resistance tests include ones for carbapenem resistance in organisms with the resistance genes KPC, NDM-1, and OXA-48; carbapenem and colistin resistance in organisms with the resistance genes VIM, GES, and mcr-1; and vancomycin resistance in organisms with the resistance genes vanA, vanB, vanC1, and vanC2/3.

Birmingham, Alabama-based BioGx now has 11 CE-marked tests that run on the BD Max system — including ones for influenza A, influenza B, respiratory syncytial virus, mycoplasma/ureaplasma genital infections, Pneumocystis jirovecii infection, tuberculosis, and Bordetella infection — and expects to receive CE marking on an additional 10 before the end of the year.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.